143 related articles for article (PubMed ID: 1663837)
1. Synthesis and structure-activity relationships of N-substituted 2-[(2-imidazolylsulfinyl)methyl]anilines as a new class of gastric H+/K(+)-ATPase inhibitors.
Yamakawa T; Matsukura H; Nomura Y; Yoshioka M; Masaki M; Igata H; Okabe S
Chem Pharm Bull (Tokyo); 1991 Jul; 39(7):1746-52. PubMed ID: 1663837
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of substituted 2-[(2-imidazolylsulfinyl)methyl]anilines as a new class of gastric H+/K(+)-ATPase inhibitors. II.
Yamakawa T; Matsukura H; Nomura Y; Yoshioka M; Masaki M; Harada H; Okabe S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):675-82. PubMed ID: 1319287
[TBL] [Abstract][Full Text] [Related]
3. Substituted 2-[(2-benzimidazolylsulfinyl)methyl]anilines as potential inhibitors of H+/K+ ATPase.
Adelstein GW; Yen CH; Haack RA; Yu S; Gullikson G; Price DV; Anglin C; Decktor DL; Tsai H; Keith RH
J Med Chem; 1988 Jun; 31(6):1215-20. PubMed ID: 2836591
[TBL] [Abstract][Full Text] [Related]
4. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
5. A substituted thieno[3.4-d]imidazole versus substituted benzimidazoles as H+, K+-ATPase inhibitors.
Herling AW; Bickel M; Lang HJ; Weidmann K; Rösner M; Metzger H; Rippel R; Nimmesgern H; Scheunemann KH
Pharmacology; 1988; 36(5):289-97. PubMed ID: 2841691
[TBL] [Abstract][Full Text] [Related]
6. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.
Zimmermann PJ; Buhr W; Brehm C; Palmer AM; Feth MP; Senn-Bilfinger J; Simon WA
Bioorg Med Chem Lett; 2007 Oct; 17(19):5374-8. PubMed ID: 17723299
[TBL] [Abstract][Full Text] [Related]
7. Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines.
Ife RJ; Brown TH; Keeling DJ; Leach CA; Meeson ML; Parsons ME; Reavill DR; Theobald CJ; Wiggall KJ
J Med Chem; 1992 Sep; 35(18):3413-22. PubMed ID: 1326634
[TBL] [Abstract][Full Text] [Related]
8. Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme.
Kaminski JJ; Wallmark B; Briving C; Andersson BM
J Med Chem; 1991 Feb; 34(2):533-41. PubMed ID: 1847427
[TBL] [Abstract][Full Text] [Related]
9. [Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
Tomoi M; Itoh H; Ueda S; Ono T; Shibayama F
Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):105-11. PubMed ID: 2852155
[TBL] [Abstract][Full Text] [Related]
10. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
[TBL] [Abstract][Full Text] [Related]
11. Scopadulciol, an inhibitor of gastric H+, K(+)-ATPase from Scoparia dulcis, and its structure-activity relationships.
Hayashi T; Asano S; Mizutani M; Takeguchi N; Kojima T; Okamura K; Morita N
J Nat Prod; 1991; 54(3):802-9. PubMed ID: 1659612
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-a]pyridines.
Briving C; Andersson BM; Nordberg P; Wallmark B
Biochim Biophys Acta; 1988 Dec; 946(2):185-92. PubMed ID: 2850003
[TBL] [Abstract][Full Text] [Related]
13. Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors.
Sih JC; Im WB; Robert A; Graber DR; Blakeman DP
J Med Chem; 1991 Mar; 34(3):1049-62. PubMed ID: 1848293
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity.
Sanfilippo PJ; Urbanski M; Press JB; Hajos ZG; Shriver DA; Scott CK
J Med Chem; 1988 Sep; 31(9):1778-85. PubMed ID: 2842503
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
[TBL] [Abstract][Full Text] [Related]
16. 2-[(2-Aminobenzyl)sulfinyl]-1-(2-pyridyl)-1,4,5,6-tetrahydrocyclopent[d]imidazoles as a novel class of gastric H+/K+-ATPase inhibitors.
Yamada M; Yura T; Morimoto M; Harada T; Yamada K; Honma Y; Kinoshita M; Sugiura M
J Med Chem; 1996 Jan; 39(2):596-604. PubMed ID: 8558532
[TBL] [Abstract][Full Text] [Related]
17. Soraprazan: setting new standards in inhibition of gastric acid secretion.
Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
[TBL] [Abstract][Full Text] [Related]
18. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
19. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
